The Research and Development team at Universal Cells spearheads the innovative application and enhancement of the company's genome editing technology to develop universally compatible stem cell therapies. This team, composed of highly specialized scientists and leaders in areas such as immunology, gene editing, and cell therapy, focuses on advancing the science behind immune rejection prevention, optimizing clinical processes, and managing cell therapy programs. They drive the discovery and refinement of therapeutic solutions that can be commercialized as off-the-shelf products for a wide range of patients.
Akina Hoshino
Director, Clinical Gene Editin...
Annie Chen
Group Lead, Clinical Gene Edit...
Katie Lombardo
Associate Director, Research, ...
Kyle Knobloch
Senior Director, Cell Therapy ...
Lewis Lanier
Senior Director, NK Biology & ...
Mark Orr
Senior Director, NK Biology & ...
Mary Prieve
Executive Director, Head Of Re...
Noboru Yamaji
Vice President, Executive Scie...
Ryan Davis
Director Of Research
Steve Kattman
Senior Director, Research, Imm...
View all